GYRE R&D to Revenue
Gyre Therapeutics Inc · R&D to Revenue
GYRE R&D to Revenue
Latest reported11.75%period ending
GYRE FY R&D/Revenue (478.68% → 11.75%)
Latest values, visible window
High-resolution chart · PNG
GYRE r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 11.7491% | |
| 11.3695% | |
| 12.1463% | |
| 16.3124% | |
| 879.9945% | |
| 252.8881% | |
| 0% | |
| 357,900% | |
| 1,261.9843% | |
| 2,895.99% | |
| 340.4571% | |
| 290.513% | |
| 1,070.2673% | |
| 84.8375% | |
| 97.5194% | |
| 75.3048% | |
| 160.3184% | |
| 204.0378% | |
| 299.0644% | |
| 79.1206% | |
| 2,055.3533% | |
| 609.1119% | |
| 739.585% | |
| 710.5862% | |
| 478.6847% |